BG
CHRS icon

BlackRock Group’s Coherus Oncology CHRS Stock Holding History

BlackRock Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$336K Buy
11,927
+2,131
+22% +$59.6K ﹤0.01% 2489
2016
Q3 		$263K Sell
9,796
-385
-4% -$10.5K ﹤0.01% 2533
2016
Q2 		$172K Sell
10,181
-99
-1% -$1.86K ﹤0.01% 2631
2016
Q1 		$218K Buy
10,280
+7,298
+245% +$120K ﹤0.01% 2546
2015
Q4 		$69K Buy
2,982
+2,043
+218% +$52.6K ﹤0.01% 2769
2015
Q3 		$19K Buy
+939
New +$28.6K ﹤0.01% 2982

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's CHRS Position: Q4 2016 in Review

BlackRock Group increased its Coherus Oncology (CHRS) stake by 22% in Q4 2016, buying an estimated $59.6K and bringing the position to 11,927 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2489.

BlackRock Group first reported a position in CHRS in Q3 2015 and has held it in 6 quarters since. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

  • BlackRock Group held 11,927 shares of Coherus Oncology worth $336K as of Q4 2016.
  • BlackRock Group bought 2,131 Coherus Oncology shares in Q4 2016, an estimated $59.6K.
  • Coherus Oncology made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2489 holding.
  • BlackRock Group first reported a position in Coherus Oncology in Q3 2015 and has held it in 6 quarters since.
  • 122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.